1-2 of 2
Stefan D Gross
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Elvn-001, a Next Generation ATP-Competitive ABL1 Tyrosine Kinase Inhibitor for the Treatment of Chronic Myeloid Leukemia

Stefan D Gross, Christopher A. Eide, Michael R Burkard, Anna Reister Schultz, Monette A Aujay, Samuel Kintz, Brian J. Druker, Joseph P Lyssikatos
Journal: Blood
Blood (2022) 140 (Supplement 1): 3095–3096.
https://doi.org/10.1182/blood-2022-162700
Published: 2022
Journal Articles

Activity of ARRY-614, an Inhibitor of p38 Map Kinase and Angiogenic Targets, in Hematologic Malignancies.

Shannon L. Winski, PhD, Stefan D. Gross, PhD, Suzy A. Brown, BS, Deborah Anderson, BS, Augusta Garrison, MS, Mareli Rodriguez, MS, Patrice Lee, PhD, Mark Munson, PhD, James Winkler, PhD
Journal: Blood
Blood (2007) 110 (11): 4798.
https://doi.org/10.1182/blood.V110.11.4798.4798
Published: 2007